Bicycle Therapeutics
Bicycle Therapeutics is an England-based biotechnology company that develops and commercializes novel therapeutics for the treatment of cancer and inflammatory diseases.
Business Model:
Revenue: $15M
Employees: 51-200
Industries / Tags:
Detailed Bicycle Therapeutics Information
Geographic Data
Address: B900, Babraham Research Campus
City: Cambridge
State: england
Zip: CB22 3AT
Country: GB
Financial Info
Stage:
post ipo equity
Raised Last:
$175M
Raised Total:$343M
Social
Metrics
3,099,739Website Global Rank
5,402Website Monthly Traffic
Twitter Followers
Description
Bicycle Therapeutics is an England-based biotechnology company that develops and commercializes novel therapeutics for the treatment of cancer and inflammatory diseases.
Contact Phone:
Contact Email:
Bicycle Therapeutics went public on 5/23/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/23/2019
IPO Valuation:
$248M
Ticker Symbol:
BCYC
IPO Price:
$14/share
Amount Raised:
$61M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
